A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi

Key facts

Sponsor

Vaccinex Inc.

Principal Investigator

Andrew Feigin, MD

The Marlene & Paolo Fresco Institute for Parkinson's & Movement Disorders-NYU Langone Medical Center

Intervention

VX15/2503(drug)

Enrollment

301 enrolled

Eligibility

21 years · All sexes

Timeline

2015 – 2020

Study locations (30)

• University of Alabama at Birmingham, Birmingham, Alabama, United States
• University of California, San Diego, La Jolla, California, United States
• University of California San Francisco, San Francisco, California, United States
• University of Colorado - Denver, Aurora, Colorado, United States
• Georgetown University, Washington D.C., District of Columbia, United States
• University of Florida Gainesville, Gainesville, Florida, United States
• Emory University School of Medicine, Atlanta, Georgia, United States
• Indiana University School of Medicine, Indianapolis, Indiana, United States
• University of Iowa, Iowa City, Iowa, United States
• University of Louisville, Louisville, Kentucky, United States
• Johns Hopkins University, Baltimore, Maryland, United States
• Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
• Massachusetts General Hospital, Charlestown, Massachusetts, United States
• University of Michigan, Ann Arbor, Michigan, United States
• Washington University, St Louis, Missouri, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

Huntington Study Group

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Huntington's Disease

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1NCT07246941
  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease
  Hoffmann-La Roche
• RECRUITINGNANCT06807892
  Comparison of Two Cognitive-Motor Rehabilitation Approaches Via Exergames: a Study of Cognitive, Motor and Behavioral Functions in Huntington's Disease Patients
  University Hospital, Angers
• RECRUITINGNANCT07299682
  Facilitating Effective Eating With DoddleBags: A Single-Arm Acceptability Study Of DoddleBags to Assess Impact on Self Feeding Behaviours in a Huntington's Disease Population
  University of Hull
• RECRUITINGPHASE1NCT06585449
  A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
  Alnylam Pharmaceuticals
• ACTIVE NOT RECRUITINGNCT07503743
  Biology-Driven Cognitive Profiling in Huntington's Disease
  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
• ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04120493
  Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease
  UniQure Biopharma B.V.
• RECRUITINGNCT02855476
  HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
  University College, London
• RECRUITINGNCT01574053
  Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
  CHDI Foundation, Inc.

See all trials for Huntington's Disease →